| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |